DrugPatentWatch Database Preview
Drugs in Development Information for Phenylacetic acid
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Phenylacetic acid?
Phenylacetic acid is an investigational drug.
There have been 4 clinical trials for Phenylacetic acid.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.
The most common disease conditions in clinical trials are Drug-Related Side Effects and Adverse Reactions, Urea Cycle Disorders, Inborn, and Disease. The leading clinical trial sponsors are Horizon Pharma Ireland, Ltd., Dublin Ireland, Shijiazhuang Yiling Pharmaceutical Co. Ltd, and Horizon Therapeutics, LLC.
There are three US patents protecting this investigational drug and forty-one international patents.
Summary for Phenylacetic acid
| US Patents | 3,056 |
| International Patents | 41,238 |
| US Patent Applications | 3,858 |
| WIPO Patent Applications | 1,897 |
| Japanese Patent Applications | 6 |
| Clinical Trial Progress | Phase 1 (2017-11-01) |
| Vendors | 47 |
Recent Clinical Trials for Phenylacetic acid
| Title | Sponsor | Phase |
|---|---|---|
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Shijiazhuang Yiling Pharmaceutical Co. Ltd | Phase 1 |
| Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders | Horizon Therapeutics, LLC | Phase 4 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Yiling Pharmaceutical Inc. | Phase 1 |
Clinical Trial Summary for Phenylacetic acid
Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid
US Patents for Phenylacetic acid
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Phenylacetic acid | Start Trial | Compounds for the treatment of infectious diseases | Hoffmann-La Roche Inc. (Little Falls, NJ) | Start Trial |
| Phenylacetic acid | Start Trial | 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Phenylacetic acid | Start Trial | Beta-lactamases with improved properties for therapy | SYNTHETIC BIOLOGICS, INC. (Rockville, MD) | Start Trial |
| Phenylacetic acid | Start Trial | Selective androgen receptor degrader (SARD) ligands and methods of use thereof | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN) GTX, INC. (Memphis, TN) | Start Trial |
| Phenylacetic acid | Start Trial | Fused heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Phenylacetic acid
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Phenylacetic acid | China | 107001386 | 2034-10-11 | Start Trial |
| Phenylacetic acid | European Patent Office | 3204392 | 2034-10-11 | Start Trial |
| Phenylacetic acid | Japan | 2017531655 | 2034-10-11 | Start Trial |
| Phenylacetic acid | World Intellectual Property Organization (WIPO) | 2016055553 | 2034-10-11 | Start Trial |
| Phenylacetic acid | Argentina | 104884 | 2035-06-03 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
